20
Jan

Dr. Eric Wickstrom Elected AAAS Fellow

Eric Wickstrom, Ph.D., of Jefferson Medical College, Kimmel Cancer Center, recognized for creating new methods to see cancer gene activity from outside the body Exemplary work in genetic imaging and therapy have earned  Eric Wickstrom, Ph.D., a Professor of Biochemistry & Molecular Biology at Jefferson Medical College of Thomas Jefferson University and member of the …

24
Nov

Loss of the retinoblastoma tumor suppressor pushes prostate cancer into lethal stage, say Kimmel Cancer Center researchers

Their study, the first to uncover a new role for this powerful gene, may lead to clinical “barcoding” of a patient’s prostate cancer to help direct therapy (PHILADELPHIA) – The retinoblastoma tumor suppressor gene (Rb), long thought to protect cells against cancer development, appears to play a very different role in prostate cancer, say scientists …

11
Oct

CancerCare Awards Dr. Edith Mitchell With Physician Of The Year Award

The national nonprofit CancerCare presented its Physician of the Year Awards to two nationally recognized leaders in oncology and cancer patient care during its annual “Tribute to Our Friends” awards ceremony, held on September 30 at CancerCare’s national office in New York City. On of the “Physician of the Year Awards” was presented top Dr. …

29
Sep

“How & Why” Cancer Cells Eat Us Alive

Four key studies now propose a new theory about how cancer cells grow and survive, allowing researchers to design better diagnostics and therapies to target high-risk cancer patients.  These studies were conducted by a large team of researchers at Thomas Jefferson University’s Kimmel Cancer Center.

1
Jun

Reception to Celebrate Dr. Dicker’s Appointment as Chairman

A reception to celebrate Dr. Adam Dicker’s appointment as Chairman of Radiation Oncology was held in the Hamilton Building on Wednesday May 26, 2010. For more about Dr. Dicker’s appointment please go here

24
May

Scientists Find Protein Spurs Spread of Prostate Cancer

Researchers from the Kimmel Cancer Center at Jefferson have found that Stat5, a signaling protein previously found to be key to survival of prostate cancer, is also involved in metastasis. Their study, published in the online edition of Endocrine-Related Cancer, demonstrates in both laboratory and animal models that nuclear Stat5 over-expression leads to a deadly …

19
May

Small RNA Molecules Block Breast Cancer from Spreading via Newly Identified Secreted Factor

The role of genes and proteins in cancer control is well known, but now researchers at Jefferson’s Kimmel Cancer Center have found a cluster of microRNA (miRNA) molecules that act to suppress the invasive spread of breast cancer. MiRNAs are non-coding small RNA molecules found in wide areas of the genome that, either singly or …

19
May

Clue to Switch of Bladder Cancer from Locally Contained to Invasive Found by Jefferson Scientists

Bladder cancer often becomes aggressive and spreads in patients despite treatment, but now researchers at the Kimmel Cancer Center at Jefferson have identified a protein they believe is involved in pushing tumors to become invasive – and deadly. “We have found that IGF-IR is a critical regulator of motility and invasion of bladder cancer cells, …

2
Apr

Dr. Leonard G. Gomella Studies the Effect of Dutasteride on the Risk of Prostate Cancer

Dr. Leonard G. Gomella and colleagues conducted a landmark international randomized, double-blind, placebo-controlled, parallel-group multi-center clinical trial to determine whether dutasteride reduces the risk of incident prostate cancer, as detected on biopsy, among men who are at increased risk for the disease. Over the course of the 4-year study period, dutasteride reduced the risk of …

Page 4 of 4